IP Library Granted Patent US 6,991,915
Granted Patent B2
US 6,991,915 · App. 10/202,879 · Granted Jan 31, 2006

Modified Cdc14 phosphatase proteins and constructs for improved expression and purification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,991,915
App. No.
10/202,879
Granted
Jan 31, 2006
Kind
B2
Abstract

The present invention provides modified Cdc14 phosphatase proteins, and novel constructs for expression thereof, in which the sequence C-terminal to the catalytic domain has been deleted. This modification results in the expression of a single form of the enzyme, enabling purification of a homogeneous preparation of active enzyme at a high yield.

Claims (3)

1. An isolated polypeptide, wherein the amino acid sequence of said polypeptide consists of SEQ ID NO:1.

2. A method for identifying an inhabitor of the polypeptide of claim 1 , the method comprising contacting the polypeptide with an agent and determining whether the agent inhibits the phosphatase activity of the polypeptide.

3. A method for identifying an agent that binds to the polypeptide of claim 1 , the method comprising coutacting the polypeptide with an agent and determining wheather a complex is formed with the agent bound to the polypeptide.

Assignments (3)
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →